Neuroprotective Effect of Leukemia Inhibitory Factor on Antimycin A-Induced Oxidative Injury in Differentiated PC12 Cells

详细信息    查看全文

• 作者：Yangguang Han (1)
  Jing Xu (1)
  Zhigui Li (1)
  Zhuo Yang (1)
  
• 关键词：Leukemia Inhibitory Factor ; Antimycin A ; PC12 cells ; Apoptosis ; Reactive oxygen species ; Superoxide dismutase
• 刊名：Journal of Molecular Neuroscience
• 出版年：2013
• 出版时间：July 2013
• 年：2013
• 卷：50
• 期：3
• 页码：577-585
• 全文大小：539KB
• 参考文献：1. Allen RG, Tresini M (2000) Oxidative stress and gene regulation. Free Radic Biol Med 28(3):463-99 CrossRef
  2. Anbarasi K, Vani G, Balakrishna K, Devi CS (2006) Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci 78(12):1378-384. doi:10.1016/j.lfs.2005.07.030 CrossRef
  3. Auernhammer CJ, Chesnokova V, Melmed S (1998) Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology 139(5):2201-208 CrossRef
  4. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120(4):483-95. doi:10.1016/j.cell.2005.02.001 CrossRef
  5. Basoah A, Matthews PM, Morten KJ (2005) Rapid rates of newly synthesized mitochondrial protein degradation are significantly affected by the generation of mitochondrial free radicals. FEBS Lett 579(28):6511-517. doi:10.1016/j.febslet.2005.10.029 CrossRef
  6. Blass JP, Gibson GE (1991) The role of oxidative abnormalities in the pathophysiology of Alzheimer’s disease. Rev Neurol (Paris) 147(6-):513-25
  7. Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH (1999) Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci 19(9):3556-566
  8. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA, Emery B, Turnley AM, Petratos S, Ernst M, Bartlett PF, Kilpatrick TJ (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8(6):613-19. doi:10.1038/nm0602-613 CrossRef
  9. Campo ML, Kinnally KW, Tedeschi H (1992) The effect of antimycin A on mouse liver inner mitochondrial membrane channel activity. J Biol Chem 267(12):8123-127
  10. Choi EM (2011a) Deoxyactein Isolated from / Cimicifuga racemosa protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity. J Appl Toxicol. doi:10.1002/jat.1784
  11. Choi EM (2011b) Protective effect of diazoxide against antimycin A-induced mitochondrial dysfunction in osteoblastic MC3T3-E1 cells. Toxicol In Vitro 25(8):1603-608. doi:10.1016/j.tiv.2011.06.004 CrossRef
  12. Choi EM, Lee YS (2011) Mitochondrial defects and cytotoxicity by antimycin A on cultured osteoblastic MC3T3-E1 cells. Food Chem Toxicol 49(9):2459-463. doi:10.1016/j.fct.2011.04.037 CrossRef
  13. Choi EM, Lee YS (2012) Protective effect of apocynin on antimycin A-induced cell damage in osteoblastic MC3T3-E1 cells. J Appl Toxicol 32(9):714-21. doi:10.1002/jat.1689 CrossRef
  14. Chollangi S, Wang J, Martin A, Quinn J, Ash JD (2009) Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina. Neurobiol Dis 34(3):535-44. doi:10.1016/j.nbd.2009.03.012 CrossRef
  15. Contestabile A (2001) Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr Top Med Chem 1(6):553-68 CrossRef
  16. de Souza WR, Vessecchi R, Dorta DJ, Uyemura SA, Curti C, Vargas-Rechia CG (2011) Characterization of / Rubus fruticosus mitochondria and salicylic acid inhibition of reactive oxygen species generation at Complex III/Q cycle: potential implications for hypersensitive response in plants. J Bioenerg Biomembr 43(3):237-46. doi:10.1007/s10863-011-9357-4 CrossRef
  17. Dinis-Oliveira RJ, Remiao F, Carmo H, Duarte JA, Navarro AS, Bastos ML, Carvalho F (2006) Paraquat exposure as an etiological factor of Parkinson’s disease. Neurotoxicology 27(6):1110-122. doi:10.1016/j.neuro.2006.05.012 CrossRef
  18. Fukui K, Takatsu H, Shinkai T, Suzuki S, Abe K, Urano S (2005) Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J Alzheimers Dis 8(3):299-09
  19. Gao Y, Dong C, Yin J, Shen J, Tian J, Li C (2012) Neuroprotective effect of fucoidan on H2O2-induced apoptosis in PC12 cells via activation of PI3K/Akt pathway. Cell Mol Neurobiol 32(4):523-29. doi:10.1007/s10571-011-9792-0 CrossRef
  20. Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D (1987) Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 6(13):3995-002
  21. Guha G, Mandal T, Rajkumar V, Ashok Kumar R (2010) Antimycin A-induced mitochondrial apoptotic cascade is mitigated by phenolic constituents of / Phyllanthus amarus aqueous extract in Hep3B cells. Food Chem Toxicol 48(12):3449-457. doi:10.1016/j.fct.2010.09.020 CrossRef
  22. Gupta RC (2004) Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol Mech Methods 14(3):103-43. doi:10.1080/15376520490429175 CrossRef
  23. Han YH, Park WH (2009a) Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis. Lung Cancer 65(2):150-60. doi:10.1016/j.lungcan.2008.11.005 CrossRef
  24. Han YH, Park WH (2009b) Tiron, a ROS scavenger, protects human lung cancer Calu-6 cells against antimycin A-induced cell death. Oncol Rep 21(1):253-61
  25. Han YH, Kim SH, Kim SZ, Park WH (2008a) Antimycin A as a mitochondrial electron transport inhibitor prevents the growth of human lung cancer A549 cells. Oncol Rep 20(3):689-93
  26. Han YH, Kim SH, Kim SZ, Park WH (2008b) Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int J Oncol 33(5):1099-105
  27. Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH (2009) p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion. Anticancer Res 29(11):4423-431
  28. Heo SR, Han AM, Kwon YK, Joung I (2009) p62 protects SH-SY5Y neuroblastoma cells against H2O2-induced injury through the PDK1/Akt pathway. Neurosci Lett 450(1):45-0. doi:10.1016/j.neulet.2008.11.011 CrossRef
  29. Hilton DJ, Nicola NA, Metcalf D (1988) Purification of a murine leukemia inhibitory factor from Krebs ascites cells. Anal Biochem 173(2):359-67 CrossRef
  30. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75(2):241-51 CrossRef
  31. Hu J, Imai T, Shimizu N, Nakagawa H, Ono S (1999) Expression of leukaemia inhibitory factor in skin of patients with amyotrophic lateral sclerosis. Lancet 353(9170):2126-127. doi:10.1016/S0140-6736(99)01520-2 CrossRef
  32. Hughes RA, Sendtner M, Thoenen H (1993) Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 36(6):663-71. doi:10.1002/jnr.490360607 CrossRef
  33. Jo C, Kim H, Jo I, Choi I, Jung SC, Kim J, Kim SS, Jo SA (2005) Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochim Biophys Acta 1743(3):187-97. doi:10.1016/j.bbamcr.2004.11.002 CrossRef
  34. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262(5137):1274-277 CrossRef
  35. King MA (2005) Antimycin A-induced killing of HL-60 cells: apoptosis initiated from within mitochondria does not necessarily proceed via caspase 9. Cytometry A 63(2):69-6. doi:10.1002/cyto.a.20107
  36. Kotzbauer PT, Lampe PA, Estus S, Milbrandt J, Johnson EM Jr (1994) Postnatal development of survival responsiveness in rat sympathetic neurons to leukemia inhibitory factor and ciliary neurotrophic factor. Neuron 12(4):763-73 CrossRef
  37. Kurek JB, Nouri S, Kannourakis G, Murphy M, Austin L (1996) Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 19(10):1291-301. doi:10.1002/(SICI)1097-4598(199610)19:10<1291::AID-MUS6>3.0.CO;2-9 CrossRef
  38. Kurek JB, Bennett TM, Bower JJ, Muldoon CM, Austin L (1998) Leukaemia inhibitory factor (LIF) production in a mouse model of spinal trauma. Neurosci Lett 249(1):1- CrossRef
  39. Lai B, Zhang L, Dong LY, Zhu YH, Sun FY, Zheng P (2005) Inhibition of Qi site of mitochondrial complex III with antimycin A decreases persistent and transient sodium currents via reactive oxygen species and protein kinase C in rat hippocampal CA1 cells. Exp Neurol 194(2):484-94. doi:10.1016/j.expneurol.2005.03.005 CrossRef
  40. Lane N (2006) Mitochondrial disease: powerhouse of disease. Nature 440(7084):600-02. doi:10.1038/440600a CrossRef
  41. Liu S, Han Y, Zhang T, Yang Z (2011) Protective effect of trifluoperazine on hydrogen peroxide-induced apoptosis in PC12 cells. Brain Res Bull 84(2):183-88. doi:10.1016/j.brainresbull.2010.12.008 CrossRef
  42. Ma S, Liu H, Jiao H, Wang L, Chen L, Liang J, Zhao M, Zhang X (2012) Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca(2+) influx. Neurotoxicology 33(1):59-9. doi:10.1016/j.neuro.2011.11.003 CrossRef
  43. Maguire JJ, Kagan VE, Packer L (1992) Electron transport between cytochrome c and alpha tocopherol. Biochem Biophys Res Commun 188(1):190-97 CrossRef
  44. Mallis RJ, Buss JE, Thomas JA (2001) Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem J 355(Pt 1):145-53 CrossRef
  45. Martinou JC, Martinou I, Kato AC (1992) Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motoneurons in vitro. Neuron 8(4):737-44 CrossRef
  46. Mattson MP, Pedersen WA (1998) Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer’s disease. Int J Dev Neurosci 16(7-):737-53 CrossRef
  47. Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases. Ann N Y Acad Sci 893:154-75 CrossRef
  48. Murphy M, Reid K, Brown MA, Bartlett PF (1993) Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons. Development 117(3):1173-182
  49. Nakashima K, Wiese S, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Yoshida K, Kishimoto T, Sendtner M, Taga T (1999) Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci 19(13):5429-434
  50. Nakayama K, Okamoto F, Harada Y (1956) Antimycin A: isolation from a new Streptomyces and activity against rice plant blast fungi. J Antibiot (Tokyo) 9(2):63-6
  51. Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, Walsh K, Kishimoto T, Yamauchi-Takihara K (2001) Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 103(4):555-61 CrossRef
  52. Noor R, Mittal S, Iqbal J (2002) Superoxide dismutase—applications and relevance to human diseases. Med Sci Monit 8(9):RA210–RA215
  53. Panduri V, Weitzman SA, Chandel NS, Kamp DW (2004) Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol 286(6):L1220–L1227. doi:10.1152/ajplung.00371.2003 CrossRef
  54. Park WH, Han YW, Kim SH, Kim SZ (2007a) An ROS generator, antimycin A, inhibits the growth of HeLa cells via apoptosis. J Cell Biochem 102(1):98-09. doi:10.1002/jcb.21280 CrossRef
  55. Park WH, Han YW, Kim SW, Kim SH, Cho KW, Kim SZ (2007b) Antimycin A induces apoptosis in As4.1 juxtaglomerular cells. Cancer Lett 251(1):68-7. doi:10.1016/j.canlet.2006.11.002 CrossRef
  56. Pham NA, Robinson BH, Hedley DW (2000) Simultaneous detection of mitochondrial respiratory chain activity and reactive oxygen in digitonin-permeabilized cells using flow cytometry. Cytometry 41(4):245-51. doi:10.1002/1097-0320(20001201)41:4<245::AID-CYTO2>3.0.CO;2-# CrossRef
  57. Plisov SY, Yoshino K, Dove LF, Higinbotham KG, Rubin JS, Perantoni AO (2001) TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. Development 128(7):1045-057
  58. Rao AV, Balachandran B (2002) Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 5(5):291-09 CrossRef
  59. Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE, Brulet P, Landis SC (1993) Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 11(6):1175-185 CrossRef
  60. Ren SG, Seliktar J, Li X, Hershman JM, Braunstein GD, Melmed S (1999) In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism. J Clin Endocrinol Metab 84(8):2883-887 CrossRef
  61. Robak J, Marcinkiewicz E (1995) Scavenging of reactive oxygen species as the mechanism of drug action. Pol J Pharmacol 47(2):89-8
  62. Sandri M, Carraro U (1999) Apoptosis of skeletal muscles during development and disease. Int J Biochem Cell Biol 31(12):1373-390 CrossRef
  63. Thaler CD, Suhr L, Ip N, Katz DM (1994) Leukemia inhibitory factor and neurotrophins support overlapping populations of rat nodose sensory neurons in culture. Dev Biol 161(2):338-44. doi:10.1006/dbio.1994.1035 CrossRef
  64. Tham S, Dowsing B, Finkelstein D, Donato R, Cheema SS, Bartlett PF, Morrison WA (1997) Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res 47(2):208-15. doi:10.1002/(SICI)1097-4547(19970115)47:2<208::AID-JNR9>3.0.CO;2-J CrossRef
  65. Tidball JG (2005) Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288(2):R345–R353. doi:10.1152/ajpregu.00454.2004 CrossRef
  66. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M (1984) Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259(17):10978-0982
  67. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44-4. doi:10.1016/j.biocel.2006.07.001 CrossRef
  68. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, Breuer R (2006) Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 290(4):L790–L796. doi:10.1152/ajplung.00300.2004 CrossRef
  69. White JD, Davies M, Grounds MD (2001) Leukaemia inhibitory factor increases myoblast replication and survival and affects extracellular matrix production: combined in vivo and in vitro studies in post-natal skeletal muscle. Cell Tissue Res 306(1):129-41 CrossRef
  70. Wysoczynski M, Miekus K, Jankowski K, Wanzeck J, Bertolone S, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ (2007) Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res 67(5):2131-140. doi:10.1158/0008-5472.CAN-06-1021 CrossRef
  71. Xi YD, Yu HL, Ma WW, Ding BJ, Ding J, Yuan LH, Feng JF, Xiao R (2011) Genistein inhibits mitochondrial-targeted oxidative damage induced by beta-amyloid peptide 25-5 in PC12 cells. J Bioenerg Biomembr 43(4):399-07. doi:10.1007/s10863-011-9362-7 CrossRef
  72. Xue HY, Gao GZ, Lin QY, Jin LJ, Xu YP (2012) Protective Effects of Aucubin on H2O2-induced apoptosis in PC12 cells. Phytother Res 26(3):369-74. doi:10.1002/Ptr.3562
  73. Yamamori T (1991) Localization of cholinergic differentiation factor/leukemia inhibitory factor mRNA in the rat brain and peripheral tissues. Proc Natl Acad Sci U S A 88(16):7298-302 CrossRef
  74. Yamamori T, Fukada K, Aebersold R, Korsching S, Fann MJ, Patterson PH (1989) The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246(4936):1412-416 CrossRef
  75. Zigmond RE (2011) gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury. Front Mol Neurosci 4:62. doi:10.3389/fnmol.2011.00062
  
• 作者单位：Yangguang Han (1)
  Jing Xu (1)
  Zhigui Li (1)
  Zhuo Yang (1)
  
  1. College of Medicine, Nankai University, Tianjin, 300071, China
  

文摘

As a neurotrophic cytokine, leukemia inhibitory factor (LIF) has neuroendocrine effects and exerts neuroprotective effects on various neuron injuries both in vitro and in vivo. The aim of the present study was to investigate whether LIF can protect PC12 cells from antimycin A (AMA)-induced oxidative stress. LIF (0.5 and 1?ng/ml) increased PC12 cell viability and significantly attenuated AMA-induced cell death as demonstrated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results from Hoechst 33342 staining and flow cytometry assay showed that AMA induced apoptosis significantly in PC12 cells, while pretreatment with LIF (0.5 and 1?ng/ml) can attenuate this injury. The presence of LIF partly prevented AMA-induced elevated reactive oxygen species level and decreased superoxide dismutase level, which indicated the antioxidative effects of LIF on the neuron oxidative injury. In conclusion, LIF might protect PC12 cells from the injury induced by AMA through the downregulation of oxidative stress, which may provide basic information of using LIF as a potential targeted therapy for oxidative injury in neurons.